Cancer survival‐related studies have shown that a high AST/ALT ratio is associated with poor outcome of renal cell carcinoma,13 head and neck carcinoma,25 and oral and oropharyngeal carcinoma26 among other cancers. The gene discussed is GPT; the disease is renal cell carcinoma.